Gousses de Senna

Senna pods contain sennosides A and B, which are anthraquinone glycosides. When ingested, these compounds pass through the stomach unabsorbed and reach the colon, where gut bacteria metabolize them into active compounds called rhein anthrones. These metabolites stimulate colonic motility by increasing peristalsis and promote fluid secretion into the intestinal lumen. The result is softer stools and easier bowel movements, typically within 6-12 hours after ingestion. Evidence Level A supports this mechanism of action.

Senna pods may interact with several medications. Long-term use can cause potassium depletion, potentially increasing toxicity of cardiac glycosides like digoxin. Senna may also interact with diuretics, worsening electrolyte imbalances, and with corticosteroids. Additionally, reduced absorption of oral medications may occur due to faster gut transit time. Patients taking antiarrhythmic drugs, diuretics, or heart medications should consult a healthcare provider before using senna. Evidence Level A supports these established interactions.

The standard adult dosage for senna pods is 1-4 pods (equivalent to 15-30 mg sennosides) taken at bedtime with adequate fluids. This typically produces a bowel movement within 6-12 hours. Senna pods are considered gentler than senna leaves due to their lower sennoside concentration and additional mucilage content. Start with the lowest effective dose and do not exceed recommended amounts. Evidence Level A supports this dosing range for short-term constipation relief.

Senna pods are contraindicated during pregnancy and should not be used. The stimulant laxative action can cause uterine contractions and intestinal cramping, potentially risking pregnancy complications. Additionally, sennosides may cross the placenta, and electrolyte imbalances from laxative use could harm fetal development. Pregnant women experiencing constipation should consult their healthcare provider for safer alternatives such as dietary fiber supplements or stool softeners. Evidence Level A confirms this contraindication.

Yes, senna pods are generally considered gentler than senna leaves. The pods contain lower concentrations of sennosides and include mucilage, a soothing compound that helps reduce intestinal irritation. This combination provides a milder, longer-lasting laxative effect with less cramping compared to the leaves. Both traditional use across African, Asian, and European medicine and clinical experience support this distinction, making pods a preferred option for those seeking gentle constipation relief. Evidence Level A supports the efficacy of senna pods.

Common side effects of senna pods include abdominal cramping, bloating, and flatulence. These effects are typically mild and dose-related. More serious concerns with prolonged use include electrolyte imbalances, particularly low potassium, dehydration, and laxative dependency, where the colon becomes reliant on stimulation for bowel movements. Chronic use may also cause melanosis coli, a harmless darkening of the colon lining. Senna should only be used short-term unless directed by a healthcare provider. Evidence Level A supports these safety findings.